Salmonellosis resulting from the consumption of contaminated eggs and poultry meat poses a significant public health risk to consumers worldwide. The Centers for Disease Control and Prevention has estimated that there are approximately 2 million cases of human nontyphoid salmonellosis per year in the United States, resulting in up to 2,000 deaths (1) . Most cases of salmonellosis in developed countries are zoonotic in origin and not due to person-to-person contamination. This disease is caused by exposure to products contaminated with Salmonella, e.g., animal products (such as eggs, milk, poultry), or the ingestion of food products that have been exposed to animal feces. Economic constraints associated with improved management of production and slaughter facilities suggest that on-farm control of Salmonella via a combination of antibiotics, competitive exclusion products, and/or vaccination may be the most practical and economically feasible methods toward reducing contamination of poultry products (34) . Such a reduction in preharvest pathogen load may provide a means for decreasing the potential for transmission to humans. Dam ؊ Salmonella is attenuated for virulence in day-of-hatch chicks. Salmonella DNA adenine methylase (Dam) mutants are attenuated for virulence in mice and elicit protective (10, 16) and cross-protective (15) 7 CFU of Dam Ϫ Typhimurium UK-1 (MT2313) within 10 h of hatching and again at 1 week of age. Chicks were challenged at 5 weeks of age with 10 8 CFU of serovar Typhimurium F98 (MT2318). Vaccine efficacy was determined by comparison of vaccinate (n ϭ 62) and control (n ϭ 62) quantitative cultures of the spleen, bursa of Fabricius, ileum, cecum, and feces; cultures were performed at 2, 3, 5, 7, 9, 12, and 14 days postchallenge. The mean log 10 CFU of homologous challenge with Typhimurium F98 by organ and day of termination for vaccinated birds relative to controls are presented in Fig.  1A . Vaccination with Dam Ϫ UK-1 (MT2313) resulted in significantly lower CFU (P Ͻ 0.05) in the spleen and feces of vaccinates on all 7 postchallenge days examined. Significantly lower CFU in vaccinates relative to controls were observed in the bursa on 4 out of 7 termination days, in the ileum on 5 of 7 days, and in the cecum on 3 of 7 days.
Vaccinated birds also had significantly lower CFU than controls following homologous challenge with serovar Typhimurium F98 (MT2318) with maximum CFU/tissue/bird as the unit of analysis (Fig. 2 ). All control birds had at least 40 CFU of challenge organism in at least one organ following challenge. However, no salmonellae were isolated in any organ from 7 out of 62 (11%) vaccinates; an additional 7 out of 62 (11%) vaccinates had only 10 CFU isolated from at least one organ. In vaccinates, 32 out of 62 (52%) birds had Յ10 CFU of serovar S. enterica O6,14,24:e,h-monophasic (serogroup H; MT2339). Figure 1B and C show the mean log 10 CFU of serovars Enteritidis 4973 and S. enterica O6,14,24:e,h-monophasic challenge organisms by organ and day of termination for vaccinated birds relative to nonvaccinated controls. Six days postchallenge with serovar Enteritidis 4973 (MT2314), vaccinates had significantly lower CFU in the spleen, bursa, cecum, and feces: no challenge organisms were recovered from any vaccinated bird organs, whereas 50 to 60% of control organs were positive for Salmonella. No challenge organisms were recovered from the spleens of vaccinates on day 6 or 7 postchallenge with S. enterica serovar O6,14,24:e,h-monophasic (MT2339); in contrast, salmonellae were recovered from 19 out of 20 control spleens on these 2 days.
Vaccinated birds had significantly lower CFU than controls following heterologous challenge when the maximum CFU/ tissue/bird was used as the unit of analysis (Fig. 2) . No serovar Enteritidis 4973 was recovered from 18 out of 30 (60%) challenged vaccinates compared to only 7 out of 30 (23%) noninfected control birds. Vaccinated birds also showed protection against challenge with serovar S. enterica O6,14,24:e,h-monophasic, as 7 out of 30 (23%) vaccinates had Յ100 CFU in at least one organ; no control birds were in this category. Taken together, these data indicate that chicks vaccinated with Dam Ϫ serovar Typhimurium UK-1 elicited cross-protective immune responses to challenge with serovars Enteritidis 4973 and S. enterica O6,14,24:e,h-monophasic for the organ or maximum CFU/tissue/bird as the unit of analysis.
The safety of the food supply can be compromised by largescale animal husbandry, agricultural methods, and distribution practices that are prone to microbial contamination. This public health problem has been recently exacerbated by the emergence of pathogens that are resistant to multiple antibiotics and/or cause more debilitating forms of disease (e.g., Esche- (16) . Strains used in infection studies were grown overnight in Luria broth at 37°C with shaking. The high-frequency generalized transducing bacteriophage P22 mutant HT105/1 int-201 was used for all transductional crosses (31), and phage-free, phage-sensitive transductants were isolated as previously described (4) . Luria broth (9) and 1% lactose MacConkey agar (Difco) were the laboratory media used in these studies. Final concentrations of antibiotics (Sigma) were as follows: kanamycin, 50 g/ml; chloramphenicol, 20 g/ml. a Chicks within 10 h of hatching were infected with the S. enterica serovar Typhimurium strain indicated. Survival was assessed until 3 weeks of age. Strains used in infection studies were grown overnight in Luria broth at 37°C, and serial dilutions were performed in 0.2 M Na 2 HPO 4 buffered to pH 8.0 to the desired cell density for infection. Fertile eggs obtained from White Leghorn chickens (Specific Pathogen Free Avian Services, Charles River) were incubated and hatched in several Marsh Automatic incubators (Lyon Electric Co., Inc., Chula Vista, Calif.).
FIG. 1. Dam
Ϫ Salmonella elicits protective responses in chicken tissue sites. The protective capacity of Dam Ϫ serovar Typhimurium was assessed by orally immunizing 62 chicks with 10 7 CFU of Dam Ϫ UK-1 (MT2313) within 10 h of hatch and boosted with the same dose at 1 week of age (hatched bars); 62 additional chicks remained as nonvaccinated controls (filled bars). All chicks were challenged at 5 weeks of age with 10 8 CFU of serovar Typhimurium F98 (MT2318). Data are depicted as mean log 10 CFU by organ. Nine control and nine vaccinated chickens were terminated at 2, 3, 5, 7, 9, and 12 days postchallenge; 8 birds per group were terminated 14 days postchallenge. Cross-protective immunity was richia coli O157:H7 and Salmonella serovars Enteritidis and Typhimurium DT104). Vaccination of chickens offers a practical and economically feasible approach to reducing contamination of poultry products. Here, we show that an S. enterica serovar Typhimurium Dam Ϫ mutant was severely attenuated for virulence in day-of-hatch chicks. Additionally, chicks immunized with this Salmonella Dam Ϫ vaccine strain exhibit protective immune responses against homologous and heterologous Salmonella serotypes that are implicated in Salmonella infection of poultry. Vaccines based on altered levels of Dam activity may prove effective in controlling Salmonella contamination of poultry, meat, and dairy products derived from animals susceptible to Salmonella infection and colonization.
Enumeration of salmonellae isolated from the visceral organs and intestinal tract of vaccinated and nonvaccinated chickens challenged with virulent serovars Typhimurium or Enteritidis or S. enterica O6,14,24:e,h-monophasic was used to determine the degree of protection associated with vaccination. Significantly lower mean log 10 CFU were observed in visceral organs and the gastrointestinal tract of vaccinates versus nonvaccinates. Comparison of these results with challenge studies for other vaccines is problematic as the outcome of infection varies greatly with challenge strain, inoculation and immunization dose, use of multiple (booster) immunizations, the age of the birds at vaccination and challenge, statistical analysis of the data, etc. (11, 17, 18) . Previous studies using live attenuated Salmonella aroA (11, 17, 18) and ⌬cya ⌬crp mutants (12) showed reduced visceral invasion and colonization of the gastrointestinal tract in chickens by homologous and, to a lesser extent, heterologous challenge strains. Oral vaccination with attenuated aroA mutants of serovar Typhimurium (3) or Enteritidis (6, 7) reduced fecal shedding following homologous challenge, but not heterologous challenge (8) . Vaccination with serovar Typhimurium ⌬cya ⌬crp conferred protection against intestinal and visceral invasion by both homologous and heterologous challenge serotypes (12) . Moreover, this vaccine also provided protection against intestinal, visceral, reproductive tract and egg colonization by Salmonella for at least 11 months postvaccination, with no effect on egg production (13) .
Results of this study are promising in that significant protection was observed following homologous and heterologous challenge at high challenge doses. It should be noted that a single challenge may not reflect the field situation wherein animals can be exposed to various doses of several virulent serovars alone and in combination. That said, multiple and/or continuous exposures to several serovars in the field situation do not necessarily result in susceptibility of immunized animals to disease: repeated exposures may contribute to the maintenance of heightened levels of protection in vaccinated hosts.
The data presented here suggest that vaccines based on altered DNA methylation may reduce preharvest Salmonella contamination in poultry, ultimately decreasing the potential for food-borne transmission of this pathogen to humans. DNA
FIG. 2. Salmonella Dam
Ϫ vaccine elicits protective responses as determined by the maximum CFU/tissue/bird analysis. Vaccinated (open boxes) and nonvaccinated (closed boxes) chicks were challenged as described in the Fig. 1 legend. The maximum CFU from the five tissues examined for each bird determined the category into which the bird was included. For example, if no CFU were found in the spleen, bursa, ileum, or cecum but 10 6 CFU were found in feces, the bird was included in the Յ10 6 CFU category.
assessed as follows. Sixty chicks were orally vaccinated with 10 7 Dam Ϫ UK-1 (MT2313) cells within 10 h of hatching and again at 1 week of age; 60 additional chicks remained as nonvaccinated controls. All chicks were challenged at 5 weeks of age with either 10 8 CFU of serovar Enteritidis 4973 (MT2314) or 10 9 CFU of S. enterica serovar O6,14,24:e,h-monophasic (MT2339). Ten control and 10 vaccinated chickens were terminated at 4, 5, and 6 days postchallenge for the serovar Enteritidis challenge or 5, 6, or 7 days postchallenge for the S. enterica serovar O6,14,24:e,hmonophasic challenge. For each experiment, a separate cohort of 8 to 14 nonvaccinated, nonchallenged negative control birds were maintained and necropsied as described below. Approximately 1 g of each organ was obtained in the following order: spleen, bursa of Fabricius, ileum and ileal contents, cecum and cecal contents, and rectum and feces. Organs were weighed, homogenized, and serially diluted, and 100 l of each dilution was plated on 1% lactose MacConkey agar plates containing kanamycin. For detection of salmonellae at concentrations below 40 CFU/g, the 1:4 dilution homogenate sample was incubated for 24 h in 9 ml of tetrathionate solution, streaked for single colonies on lactose MacConkey agar, and incubated for 24 h at 37°C. Samples positive by selective enrichment in tetrathionate broth were recorded as 10 CFU, and negative samples were recorded as 0 CFU. For tissue experiments, bacterial titers were confirmed via serial dilutions plated on 1% lactose MacConkey agar; colony serotype was confirmed via standard biochemical tests (urea, triple sugar iron, and ONPG [O-nitrophenyl-␤-D-galactopyranoside]) and agglutination with appropriate antisera on two randomly selected colonies from each organ of each bird. ‫,ء‬ significant difference (P Ͻ 0.05) between vaccinates and controls as assessed by the Mann-Whitney test. (28, 33) . Since Dam and CcrM affect the virulence of such distantly related pathogens, the function of DNA methylation in virulence may emerge as a general theme in bacterial pathogenesis. The role of DNA methylation in virulence and the elicitation of protective immune responses may rely on its capacity as a global regulator of gene expression (16, 22, 24, 25, 26, 28, 29) . Dam regulates the production of a number of adhesins in E. coli (23, 32) and Salmonella (27) , as well as several genes required for Salmonella infection (14, 16) . Such ectopic gene expression may result in the production of an expanded repertoire of antigens that contribute to the heightened immunity seen in vaccinated animals (15, 16, 21) . Thus, dysregulation of Dam activity may be a means to elicit protective immune responses directed against diverse pathogens that infect a wide variety of animal hosts (24, 25) .
